Nalmefene, a reducing alcohol consumption drug, enhances oxLDL uptake in macrophages and aggravates atherosclerotic lesion through increasing expression of CD36 scavenger receptor.

○Ayano Yamada

[27P2-am1-031S] Nalmefene, a reducing alcohol consumption drug, enhances oxLDL uptake in macrophages and aggravates atherosclerotic lesion through increasing expression of CD36 scavenger receptor.

○Ayano Yamada^1,2, Mitsuhisa Koga¹, Koshun Inada³, Atsushi Yamauchi³ (1. Depart. Drug Delivery, Fac. Pharmaceut. Sci., Fukuoka Univ. , 2. Depart. Formulation Design, Grad. Sch. of Pharmaceut. Sci.,Fukuoka Univ., 3. Depart. Pharmaceut. Care & Health Sci., Fac. Pharmaceut. Sci., Fukuoka Univ. )

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.

Presentation information

[27P2-am1] Pharmacology 6

[27P2-am1-031S] Nalmefene, a reducing alcohol consumption drug, enhances oxLDL uptake in macrophages and aggravates atherosclerotic lesion through increasing expression of CD36 scavenger receptor.

Password